June 16 (Reuters) - Response Biomedical Corp RBM.TO :
* Says deal for cash consideration of $1.12 per response
share
* Entered into a definitive arrangement agreement with
1077801 B.C. Ltd, a company owned by Orbimed Asia Partners
* Says cash consideration price represents a 51% premium to
closing price of response shares
* Enters into definitive agreements for going private
transaction and private placement
Source text for Eikon:
Further company coverage: RBM.TO
(Bengaluru Newsroom)